Forbion Buys $34.6M of Braveheart Bio (BRVE) Stock
A new Form 4 filing shows Forbion Growth Opportunities Fund III Cooperatief U.A., listed as an insider of Braveheart Bio, Inc. (BRVE), purchased 1,920,000 shares of the company on August 7, 2026. The shares were bought on the open market at $18.00 apiece, for a total outlay of $34,560,000.00. Following the purchase, the fund’s directly … Read more